Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Special Purpose Needles Market size was over USD 14.2 billion in 2024 and is projected to reach USD 37.7 billion by 2037, growing at around 7.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of special purpose needles is assessed at USD 15.14 billion.
The growth of the market can be attributed to rising incidence of diabetes, cancer, spine disorders, hypertension and infectious diseases throughout the world. According in a report by World Health Organization (WHO), 1.13 billion people suffer from hypertension worldwide. Additionally, in 2019, over 1.5 million deaths were caused by diabetes. Moreover, over 10 million deaths were caused by cancer in 2020. Furthermore, advancement in government regulations for safety needles uses, growing focus on progressive healthcare systems across the globe, and increasing focus on efficiency in pharmaceutical industries are generating high potential for growth and opportunities for the special purpose needles market.
Special Purpose Needles Sector: Growth Drivers and Challenges
Growth Drivers
-
Growth of Next-Generation Microneedle and Needle-Free Injection Technology
- Awareness of Special Purposed Needles such as Pre-Filled Syringes
Challenges
-
Technical Challenges on a Product-by-Product Basis
- High Viscosity of Biological Products
Special Purpose Needles Market: Key Insights
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
7.8% |
|
Base Year Market Size (2024) |
USD 14.2 billion |
|
Forecast Year Market Size (2037) |
USD 37.7 billion |
|
Regional Scope |
|
Special Purpose Needles Segmentation
The special purpose needles market is segmented by product type into biopsy needles, hypodermic needles, and aspirating needles, out of which, the hypodermic needles segment is anticipated to hold the largest share in the global market during the forecast period on account of increased demand for hypodermic needles post Covid 19. Moreover, the COVID-19 pandemic caused 6,270,232 deaths, as of May 2022, as sourced from the World Health Organization.
Our in-depth analysis of the global market includes the following segments:
|
Product Type |
|
|
Application |
|
|
Distribution Channel |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportSpecial Purpose Needles Industry - Regional Synopsis
Asia Pacific industry is poised to dominate majority revenue share by 2037, on account of increasing demand for passive drugs, and requirement of special purpose needles especially for the rising geriatric population across the region. According to the United Nations sexual and reproductive health agency (UNFPA), 60 percent population of the world is in Asia. Further, the population above 65 years of age in India crossed 90,719,952 in 2020, while, it crossed 167,808,567 in China, as per the World Bank. So, the highest growth rate for the market over the forecast period is expected across the Asia Pacific region.
The special purpose needles market in the North America region is projected to hold the leading share in the forecast period on the back of its focus on the development of next-generation microneedle and needle-free injection technology for the growing demand of it, and increasing awareness of special purposed needles such as pre-filled syringes.
Companies Dominating the Special Purpose Needles Landscape
- Sanofi-aventis Groupe
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Terumo Group
- Smith’s Medical Inc.
- Boston Scientific Corporation
- Stryker Corporation
- Nipro Medical Corporation
- Cook Group Incorporated
- Medtronic Plc
- Cardinal Health, Inc.
- SERAG-WIESSNER GmbH & Co. KG
In the News
-
May 17, 2022: Terumo Pharmaceutical Solutions offers pre-fillable syringe solutions for demanding low dose applications such as ophthalmic.
-
April 28, 2022: Medtronic plc (MDT), a medical technology company, announced collaboration with GE to meet growing need for outpatient care.
Author Credits: Radhika Pawar
- Report ID: 199
- Published Date: Dec 23, 2024
- Report Format: PDF, PPT
